These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 20556836)

  • 21. Maintenance Adalimumab Concentrations Are Associated with Biochemical, Endoscopic, and Histologic Remission in Inflammatory Bowel Disease.
    Juncadella A; Papamichael K; Vaughn BP; Cheifetz AS
    Dig Dis Sci; 2018 Nov; 63(11):3067-3073. PubMed ID: 30006816
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Soluble urokinase plasminogen activator receptor suPAR as a marker for inflammation in pediatric inflammatory bowel disease.
    Kolho KL; Valtonen E; Rintamäki H; Savilahti E
    Scand J Gastroenterol; 2012 Sep; 47(8-9):951-5. PubMed ID: 22746351
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Application of the Porto criteria for the diagnosis of paediatric inflammatory bowel disease in a paediatric reference centre].
    Martín de Carpi J; Vila V; Varea V
    An Pediatr (Barc); 2011 Oct; 75(4):232-8. PubMed ID: 21549650
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Baseline Characteristics and Disease Phenotype in Inflammatory Bowel Disease.
    Müller KE; Lakatos PL; Kovacs JB; Arato A; Varkonyi A; Nemes E; Tarnok A; Toth G; Papp M; Solyom E; Horvath A; Guthy I; Kovacs M; Veres G;
    J Pediatr Gastroenterol Nutr; 2016 Jan; 62(1):50-5. PubMed ID: 26192700
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Frequency of detection of some markers of endothelial dysfunction in patients with inflammatory bowel diseases.
    Babayeva GH; Babayev ZM
    Ter Arkh; 2018 Apr; 90(4):12-16. PubMed ID: 30701868
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Serum Calprotectin in Adolescents With Inflammatory Bowel Disease-A Pilot Investigation.
    Carlsen K; Malham M; Hansen LF; Petersen JJH; Paerregaard A; Houen G; Wewer V
    J Pediatr Gastroenterol Nutr; 2019 May; 68(5):669-675. PubMed ID: 30628981
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Relationship of clinical symptoms with biomarkers of inflammation in pediatric inflammatory bowel disease.
    Hoekman DR; Diederen K; Koot BG; Tabbers MM; Kindermann A; Benninga MA
    Eur J Pediatr; 2016 Oct; 175(10):1335-42. PubMed ID: 27573259
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Screening for adrenal suppression in children with inflammatory bowel disease discontinuing glucocorticoid therapy.
    Sidoroff M; Kolho KL
    BMC Gastroenterol; 2014 Mar; 14():51. PubMed ID: 24661924
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Raised faecal calprotectin is associated with subsequent symptomatic relapse, in children and adolescents with inflammatory bowel disease in clinical remission.
    Diederen K; Hoekman DR; Leek A; Wolters VM; Hummel TZ; de Meij TG; Koot BG; Tabbers MM; Benninga MA; Kindermann A
    Aliment Pharmacol Ther; 2017 Apr; 45(7):951-960. PubMed ID: 28138990
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Serum Hepcidin and Iron Absorption in Paediatric Inflammatory Bowel Disease.
    Martinelli M; Strisciuglio C; Alessandrella A; Rossi F; Auricchio R; Campostrini N; Girelli D; Nobili B; Staiano A; Perrotta S; Miele E
    J Crohns Colitis; 2016 May; 10(5):566-74. PubMed ID: 26733407
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CD4+ immune response as a potential biomarker of patient reported inflammatory bowel disease (IBD) activity.
    Brandhorst G; Weigand S; Eberle C; Raddatz D; Karaus M; Oellerich M; Walson PD
    Clin Chim Acta; 2013 Jun; 421():31-3. PubMed ID: 23485644
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sphingolipid Analysis Indicate Lactosylceramide as a Potential Biomarker of Inflammatory Bowel Disease in Children.
    Filimoniuk A; Blachnio-Zabielska A; Imierska M; Lebensztejn DM; Daniluk U
    Biomolecules; 2020 Jul; 10(7):. PubMed ID: 32708181
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Total soluble and endogenous secretory receptor for advanced glycation endproducts (RAGE) in IBD.
    Meijer B; Hoskin T; Ashcroft A; Burgess L; Keenan JI; Falvey J; Gearry RB; Day AS
    J Crohns Colitis; 2014 Jun; 8(6):513-20. PubMed ID: 24291021
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antineutrophil cytoplasmic antibodies in children with inflammatory bowel disease: prevalence and diagnostic value.
    Olives JP; Breton A; Hugot JP; Oksman F; Johannet C; Ghisolfi J; Navarro J; Cézard JP
    J Pediatr Gastroenterol Nutr; 1997 Aug; 25(2):142-8. PubMed ID: 9252899
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Laboratory values in Japanese children with newly diagnosed inflammatory bowel disease.
    Takaki Y; Mizuochi T; Eda K; Ishihara J; Yamashita Y
    Pediatr Int; 2019 Jul; 61(7):720-725. PubMed ID: 31102555
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Increased circulating circular RNA_103516 is a novel biomarker for inflammatory bowel disease in adult patients.
    Ye YL; Yin J; Hu T; Zhang LP; Wu LY; Pang Z
    World J Gastroenterol; 2019 Nov; 25(41):6273-6288. PubMed ID: 31749597
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Circulating levels of leptin, adiponectin, resistin, and ghrelin in inflammatory bowel disease.
    Karmiris K; Koutroubakis IE; Xidakis C; Polychronaki M; Voudouri T; Kouroumalis EA
    Inflamm Bowel Dis; 2006 Feb; 12(2):100-5. PubMed ID: 16432373
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Imbalance of tissue inhibitors of metalloproteinases (TIMP) - 1 and - 4 serum levels, in patients with inflammatory bowel disease.
    Kapsoritakis AN; Kapsoritaki AI; Davidi IP; Lotis VD; Manolakis AC; Mylonis PI; Theodoridou AT; Germenis AE; Potamianos SP
    BMC Gastroenterol; 2008 Nov; 8():55. PubMed ID: 19036126
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Novel anti-glycan antibodies related to inflammatory bowel disease diagnosis and phenotype.
    Seow CH; Stempak JM; Xu W; Lan H; Griffiths AM; Greenberg GR; Steinhart AH; Dotan N; Silverberg MS
    Am J Gastroenterol; 2009 Jun; 104(6):1426-34. PubMed ID: 19491856
    [TBL] [Abstract][Full Text] [Related]  

  • 40. C-reactive protein as a diagnostic and prognostic factor in inflammatory bowel diseases.
    Mańkowska-Wierzbicka D; Karczewski J; Poniedziałek B; Grzymisławska M; Staszewski R; Królczyk A; Dobrowolska A; Grzymisławski M
    Postepy Hig Med Dosw (Online); 2016 Nov; 70(0):1124-1130. PubMed ID: 27892896
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.